R F Fu Selected Research

R F Fu Research Topics

6	Hemorrhage 07/2021 - 05/2017
3	Hematologic Diseases (Blood Diseases) 01/2022 - 05/2017
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2019 - 05/2017
2	Thrombosis (Thrombus) 11/2018 - 06/2018
2	Hemophilia B (Haemophilia B) 05/2018 - 09/2017
1	Cytopenia 10/2021
1	Hypersplenism (Anemia, Splenic) 10/2021
1	Splenomegaly 10/2021
1	Infections 10/2021
1	Common Variable Immunodeficiency 10/2021
1	Thrombotic Thrombocytopenic Purpura 03/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Vomiting 12/2019
1	Nausea 12/2019
1	Dizziness (Lightheadedness) 12/2019
1	Hypertension (High Blood Pressure) 11/2018
1	Acute Promyelocytic Leukemia 06/2018
1	Disseminated Intravascular Coagulation 06/2018
1	Cerebral Infarction 01/2018
1	Chronic Disease (Chronic Diseases) 05/2017
1	Fatigue 05/2017

3	Inosine Triphosphate (ITP)IBA 12/2019 - 05/2017
2	Transaminases (Aminotransferases)IBA 12/2019 - 01/2018
2	BilirubinIBA 12/2019 - 01/2018
2	eltrombopag FDA Link 12/2019 - 01/2018
1	Protein CIBA 01/2022
1	AntithrombinsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	Fibrinogen (Factor I)FDA Link 07/2021
1	thiamine triphosphorate (TTP)IBA 03/2020
1	Contrast MediaIBA 01/2020
1	IronIBA 01/2020
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2020
1	GlucocorticoidsIBA 11/2018
1	Dacarbazine (DIC)FDA LinkGeneric 06/2018
1	Hemostatics (Antihemorrhagics)IBA 05/2018
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2018
1	Prothrombin (Factor II)IBA 09/2017
1	Rituximab (Mabthera)FDA Link 09/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2017